MARISSA HOPPEL: Open Payments
NPI 1881106672 · EAST LIVERPOOL, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$646 in 44 payments from 8 companies in 2025. Trend: 2023 $86 · 2024 $511 · 2025 $646
Food & beverage: $646
| Company | Payments | Amount |
|---|---|---|
| Braeburn Inc. | 13 | $167 |
| Indivior Inc. | 14 | $161 |
| Alkermes, Inc. | 5 | $97 |
| ABBVIE INC. | 5 | $91 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $57 |
| Vanda Pharmaceuticals Inc. | 2 | $35 |
| Otsuka America Pharmaceutical, Inc. | 1 | $21 |
| Neurocrine BioSciences, Inc. | 1 | $17 |
Products named: BRIXADI, SUBLOCADE, VIVITROL, VRAYLAR, CAPLYTA, HETLIOZ, REXULTI, INGREZZA.
Industry payments across OH — which companies pay providers there.
